SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-020510
Filing Date
2024-06-17
Accepted
2024-06-17 16:48:08
Documents
16
Period of Report
2024-06-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tgtx20240614_8k.htm   iXBRL 8-K 60971
2 EXHIBIT 3.1 ex_688590.htm EX-3.1 8468
3 EXHIBIT 10.1 ex_688591.htm EX-10.1 6478
  Complete submission text file 0001437749-24-020510.txt   219481

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20240614.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20240614_def.xml EX-101.DEF 11804
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20240614_lab.xml EX-101.LAB 15848
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20240614_pre.xml EX-101.PRE 12019
19 EXTRACTED XBRL INSTANCE DOCUMENT tgtx20240614_8k_htm.xml XML 2949
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 241048941
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)